DK2589599T3 - Hidtil ukendte hydroxy-6-heteroarylphenanthridiner og deres anvendelse som PDE4-inhibitorer - Google Patents

Hidtil ukendte hydroxy-6-heteroarylphenanthridiner og deres anvendelse som PDE4-inhibitorer

Info

Publication number: DK2589599T3
Authority: DK; Denmark
Prior art keywords: heteroarylphenanthridines; pde4 inhibitors; new hydroxy; hydroxy; new
Prior art date: 2004-03-03

Application number

DK12196702T

Other languages

English (en)

Inventor

Ulrich Kautz

Beate Schmidt

Dieter Flockerzi

Armin Hatzelmann

Christof Zitt

Degenhard Marx

Hans-Peter Kley

Johannes Barsig

Original Assignee

Takeda Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-03-03

Filing date

2005-03-02

Publication date

2014-10-06

2005-03-02 Application filed by Takeda Gmbh filed Critical Takeda Gmbh

2014-10-06 Application granted granted Critical

2014-10-06 Publication of DK2589599T3 publication Critical patent/DK2589599T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Immunology (AREA)
Dermatology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Diabetes (AREA)
Biomedical Technology (AREA)
Pulmonology (AREA)
Cardiology (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Physical Education & Sports Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Endocrinology (AREA)
Oncology (AREA)
Obesity (AREA)
Reproductive Health (AREA)
Toxicology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Hospice & Palliative Care (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)

DK12196702T 2004-03-03 2005-03-02 Hidtil ukendte hydroxy-6-heteroarylphenanthridiner og deres anvendelse som PDE4-inhibitorer DK2589599T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP04004973		2004-03-03
EP04106359		2004-12-07
EP05716889.0A EP1723135B1 (en)	2004-03-03	2005-03-02	Novel hydroxy-6-heroarylphenanthridines and their use as pde4 inhibitors

Publications (1)

Publication Number	Publication Date
DK2589599T3 true DK2589599T3 (da)	2014-10-06

Family

ID=34921303

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK05716889.0T DK1723135T5 (da)	2004-03-03	2005-03-02	Ukendte hydroxy-6-heteroarylphenanthridiner og deres anvendelse som pde4-inhibitorer
DK12196702T DK2589599T3 (da)	2004-03-03	2005-03-02	Hidtil ukendte hydroxy-6-heteroarylphenanthridiner og deres anvendelse som PDE4-inhibitorer

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK05716889.0T DK1723135T5 (da)	2004-03-03	2005-03-02	Ukendte hydroxy-6-heteroarylphenanthridiner og deres anvendelse som pde4-inhibitorer

Country Status (29)

Country	Link
US (8)	US8003798B2 (da)
EP (2)	EP2589599B1 (da)
JP (2)	JP4801039B2 (da)
KR (2)	KR101152439B1 (da)
CN (6)	CN104803974A (da)
AR (1)	AR049319A1 (da)
AU (1)	AU2005219576B2 (da)
BR (1)	BRPI0508321B1 (da)
CA (1)	CA2557752C (da)
CO (1)	CO5700749A2 (da)
CY (2)	CY1114319T1 (da)
DK (2)	DK1723135T5 (da)
EA (2)	EA014155B1 (da)
ES (2)	ES2427256T3 (da)
HK (4)	HK1207635A1 (da)
HR (2)	HRP20130828T1 (da)
IL (2)	IL177073A (da)
ME (1)	ME01955B (da)
MX (2)	MX341474B (da)
NO (2)	NO336538B1 (da)
NZ (1)	NZ549108A (da)
PL (2)	PL1723135T3 (da)
PT (2)	PT2589599E (da)
RS (2)	RS52916B (da)
SG (1)	SG182194A1 (da)
SI (2)	SI1723135T1 (da)
TW (2)	TWI404704B (da)
WO (1)	WO2005085225A1 (da)
ZA (1)	ZA200606176B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2496459C (en)	2002-08-29	2013-06-25	Altana Pharma Ag	3-hydroxy-6-phenylphenanthridines as pde-4 inhibitors
ES2400823T3 (es)	2004-02-18	2013-04-12	Takeda Gmbh	Nuevas hidroxi-6-fenilfenantridinas sustituidas con guanidinilo como inhibidores eficaces de fosfodiesterasa (PDE) 4
CN104803974A (zh)	2004-03-03	2015-07-29	塔科达有限责任公司	新的羟基-6-杂芳基菲啶及其作为pde4抑制剂的用途
US20080119505A1 (en)	2005-02-01	2008-05-22	Altana Pharma Ag	Novel 6-Pyridylphenanthridines
CA2598858A1 (en) *	2005-03-02	2006-09-08	Nycomed Gmbh	6 -heteroaryl-1, 2, 3,4,4a, 1ob-hexahydro-phenanthridines as pde-4 inhibitors for the treatment of inflammatory disorders
KR101421914B1 (ko) *	2005-03-02	2014-07-22	다케다 게엠베하	6-헤테로시클릴 치환된 헥사히드로페난트리딘 유도체의 신규한 염
NZ574710A (en) *	2006-09-07	2012-02-24	Nycomed Gmbh	Combination treatment comprising the PDE4 inhibitor Compound A ((2R,4aR, 10bR)6-(2,6-Dimethoxy-pyridin-3-yl)-9-ethoxy-8-methoxy-1 ,2,3,4,4a,10b-hexahydrophenanthridin-2-ol) for diabetes mellitus
EA200901546A1 (ru)	2007-05-17	2010-04-30	Кортекс Фармасеутикалс, Инк.	Дизамещенные амиды для усиления глутаматергических синаптических ответов
WO2009025823A1 (en) *	2007-08-21	2009-02-26	Amgen Inc.	Phosphodiesterase 10 inhibitors
WO2009109525A1 (en) *	2008-03-03	2009-09-11	Nycomed Gmbh	Use of a specific pde4 inhibitor for the treatment and/or prophylaxis of non-alcoholic fatty liver disease
AR074318A1 (es)	2008-11-14	2011-01-05	Nycomed Gmbh	Derivados heterociclicos de pirazolona, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades de las vias respiratorias.
JP2017503814A (ja) *	2014-01-22	2017-02-02	タケダゲー・エム・ベー・ハーＴａｋｅｄａＧｍｂＨ	部分的コントロール状態の重症喘息またはコントロール不良状態の重症喘息のｐｄｅ４インヒビターを用いた（およびロイコトリエン調節薬と組み合わせて用いた）治療
CN103936661B (zh) *	2014-04-04	2016-08-24	常州大学	一种6-烷基菲啶衍生物的合成方法
MA42519A (fr) *	2015-07-29	2018-06-06	Takeda Gmbh	Inhibiteur de la pde4 pour le traitement de la néphropathie diabétique
US11179384B2 (en)	2016-08-26	2021-11-23	Takeda Gmbh	Treatment of nonalcoholic fatty liver disease
AU2018234059A1 (en)	2017-03-16	2019-10-31	Takeda Gmbh	Treatment of idiopathic pulmonary fibrosis
CA3121202A1 (en)	2018-11-30	2020-06-04	Nuvation Bio Inc.	Pyrrole and pyrazole compounds and methods of use thereof
WO2020113088A1 (en)	2018-11-30	2020-06-04	Nuvation Bio Inc.	Diarylhydantoin compounds and methods of use thereof
TWI785816B (zh) *	2019-08-30	2022-12-01	國立陽明交通大學	11-芳香基噌啉[2,3-f]菲啶鹽化合物及其製造方法
TWI753296B (zh) *	2019-08-30	2022-01-21	國立陽明交通大學	11-芳香基噌啉[2,3-f]菲啶鹽化合物及其製造方法

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9027055D0 (en) *	1990-12-13	1991-02-06	Sandoz Ltd	Organic compounds
AU650953B2 (en)	1991-03-21	1994-07-07	Novartis Ag	Inhaler
US5712298A (en)	1993-07-02	1998-01-27	Byk Gulden Lomberg Chemische Fabrik Gmbh	Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors
HU221380B1 (en)	1996-01-31	2002-09-28	Byk Gulden Lomberg Chem Fab	Phosphodiesterase inhibitor phenanthridines derivatives and use thereof
DK0889886T5 (da) *	1996-03-26	2003-02-24	Altana Pharma Ag	Hidtil ukendte, i 6-stilling substituerede phenanthridiner
US6127378A (en) *	1996-03-26	2000-10-03	Byk Gulden Lomberg Chemische Fabrik Gmbh	Phenanthridines substituted in the 6 position
JPH1020274A (ja) *	1996-07-05	1998-01-23	Fujitsu Ltd	液晶表示駆動回路及び液晶表示装置
PL189641B1 (pl)	1996-11-11	2005-09-30	Altana Pharma Ag	Benzonaftyrydyny, środki farmaceutyczne je zawierające oraz zastosowanie benzonaftyrydyn
WO1998040382A1 (en)	1997-03-07	1998-09-17	Byk Gulden Lomberg Chemische Fabrik Gmbh	Novel tetrazoles
AU8106598A (en)	1997-06-03	1998-12-21	Byk Gulden Lomberg Chemische Fabrik Gmbh	Benzonaphthyridine
ES2184318T3 (es)	1997-07-25	2003-04-01	Altana Pharma Ag	6-alquilfenantridinas sustituidas.
JP2001510825A (ja)	1997-07-25	2001-08-07	ビイクグルデンロンベルクヒエーミツシエフアブリークゲゼルシヤフトミツトベシユレンクテルハフツング	新規テトラゾール誘導体
PL191094B1 (pl)	1997-07-25	2006-03-31	Altana Pharma Ag	Nowe podstawione 6-fenylofenantrydyny, środek farmaceutyczny zawierający te pochodne oraz ich zastosowanie
TR200001256T2 (tr) *	1997-11-04	2000-11-21	Pfizer Products Inc.	Terapötik olarak aktif bileşimler.
US6306869B1 (en)	1998-05-05	2001-10-23	Byk Gulden Lomberg Chemische Febrik Gmbh	N-oxides
JP2002523505A (ja)	1998-08-31	2002-07-30	ビイクグルデンロンベルクヒエーミツシエフアブリークゲゼルシヤフトミツトベシユレンクテルハフツング	Ｐｄｅ３−及びｐｄｅ−４抑制作用を有するベンゾナフチリデン−ｎ−オキシド
DE60025327T2 (de) *	1999-01-15	2006-08-24	Altana Pharma Ag	6-arylphenanthridine mit pde-iv hemmender wirkung
JP2002534506A (ja)	1999-01-15	2002-10-15	ビイクグルデンロンベルクヒエーミツシエフアブリークゲゼルシヤフトミツトベシユレンクテルハフツング	Ｐｄｅ−ｉｖ抑制作用を有する多重に置換された６−フェニルフェナントリジン
JP2002534505A (ja)	1999-01-15	2002-10-15	ビイクグルデンロンベルクヒエーミツシエフアブリークゲゼルシヤフトミツトベシユレンクテルハフツング	新規フェナントリジン−ｎ−オキシド
CZ300366B6 (cs)	1999-01-15	2009-05-06	Nycomed Gmbh	Fenylfenanthridinová sloucenina, farmaceutický prostredek s jejím obsahem a její použití
WO2000042034A1 (en)	1999-01-15	2000-07-20	Byk Gulden	Phenanthridine-n-oxides with pde-iv inhibiting activity
CN1146562C (zh) *	1999-10-25	2004-04-21	奥坦纳医药公司	作为pde4抑制剂的四氢噻喃2,3-二氮杂萘酮类衍生物
WO2001051470A1 (en)	2000-01-11	2001-07-19	Byk Gulden Lomberg Chemische Fabrik Gmbh	Phenanthridine-n-oxides
US6924292B2 (en)	2000-03-23	2005-08-02	Takeda Chemical Industries, Ltd.	Furoisoquinoline derivatives, process for producing the same and use thereof
AU2001267589A1 (en)	2000-07-14	2002-01-30	Byk Gulden Lomberg Chemische Fabrik G.M.B.H.	Cycloalkyl - or cycloalkylmethyl-substituted 6-phenylphenanthridines
WO2002005616A1 (en) *	2000-07-14	2002-01-24	Altana Pharma Ag	Novel 6-phenylphenanthridines
US6884802B2 (en)	2000-07-14	2005-04-26	Altana Pharma Ag	6-heteroarylphenanthridines
WO2002066476A1 (en)	2001-02-21	2002-08-29	Altana Pharma Ag	6-phenylbenzonaphthyridines
JP2005537312A (ja)	2002-08-17	2005-12-08	アルタナ　ファルマ　アクチエンゲゼルシャフト	新規のフェナントリジン
RS20050117A (sr)	2002-08-17	2007-06-04	Altana Pharma Ag.,	Novi benzonaftiridini
CA2496459C (en)	2002-08-29	2013-06-25	Altana Pharma Ag	3-hydroxy-6-phenylphenanthridines as pde-4 inhibitors
ES2279215T3 (es)	2002-08-29	2007-08-16	Altana Pharma Ag	2-hidroxi-6-fenilfenantridinas como inhibidores de pde-4.
RU2247262C2 (ru)	2003-05-19	2005-02-27	Федеральное государственное унитарное предприятие Российский Федеральный Ядерный Центр-Всероссийский Научно-исследовательский институт технической физики им. акад. Е.И. Забабахина (РФЯЦ- ВНИИТФ)	Плунжерный насос сверхвысокого давления
ES2400823T3 (es)	2004-02-18	2013-04-12	Takeda Gmbh	Nuevas hidroxi-6-fenilfenantridinas sustituidas con guanidinilo como inhibidores eficaces de fosfodiesterasa (PDE) 4
CN104803974A (zh)	2004-03-03	2015-07-29	塔科达有限责任公司	新的羟基-6-杂芳基菲啶及其作为pde4抑制剂的用途
AR049419A1 (es)	2004-03-03	2006-08-02	Altana Pharma Ag	Hidroxi-6-fenilfenantridinas sustituidas con heterociclilo
WO2005084104A2 (en)	2004-03-09	2005-09-15	Altana Pharma Ag	Novel isoamido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
EP1725532A1 (en)	2004-03-10	2006-11-29	Altana Pharma AG	Novel difluoroethoxy-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
KR20060130697A (ko)	2004-03-10	2006-12-19	알타나 파마 아게	신규한 아미도-치환 히드록시-6-페닐페난트리딘 및 ｐｄｅ4억제제로서의 이의 용도
AU2005221831A1 (en)	2004-03-10	2005-09-22	Nycomed Gmbh	Novel thio-containing hydroxy-6-phenylphenanthridines and their use as PDE4 inhibitors
KR101421914B1 (ko)	2005-03-02	2014-07-22	다케다 게엠베하	6-헤테로시클릴 치환된 헥사히드로페난트리딘 유도체의 신규한 염

2005
- 2005-03-02 CN CN201510101203.4A patent/CN104803974A/zh active Pending
- 2005-03-02 WO PCT/EP2005/050931 patent/WO2005085225A1/en not_active Ceased
- 2005-03-02 ES ES05716889T patent/ES2427256T3/es not_active Expired - Lifetime
- 2005-03-02 DK DK05716889.0T patent/DK1723135T5/da active
- 2005-03-02 SG SG2012043295A patent/SG182194A1/en unknown
- 2005-03-02 CN CN201510100383.4A patent/CN104803973A/zh active Pending
- 2005-03-02 JP JP2007501289A patent/JP4801039B2/ja not_active Expired - Fee Related
- 2005-03-02 MX MX2011010146A patent/MX341474B/es unknown
- 2005-03-02 PT PT12196702T patent/PT2589599E/pt unknown
- 2005-03-02 PL PL05716889T patent/PL1723135T3/pl unknown
- 2005-03-02 BR BRPI0508321-4A patent/BRPI0508321B1/pt not_active IP Right Cessation
- 2005-03-02 MX MXPA06009695A patent/MXPA06009695A/es active IP Right Grant
- 2005-03-02 AU AU2005219576A patent/AU2005219576B2/en not_active Ceased
- 2005-03-02 CA CA2557752A patent/CA2557752C/en not_active Expired - Fee Related
- 2005-03-02 ES ES12196702.0T patent/ES2505473T3/es not_active Expired - Lifetime
- 2005-03-02 RS RS20130349A patent/RS52916B/sr unknown
- 2005-03-02 CN CN2011101613875A patent/CN102295634A/zh active Pending
- 2005-03-02 HR HRP20130828TT patent/HRP20130828T1/hr unknown
- 2005-03-02 EP EP20120196702 patent/EP2589599B1/en not_active Expired - Lifetime
- 2005-03-02 PT PT57168890T patent/PT1723135E/pt unknown
- 2005-03-02 EA EA200601568A patent/EA014155B1/ru not_active IP Right Cessation
- 2005-03-02 CN CNA2005800057687A patent/CN1922170A/zh active Pending
- 2005-03-02 EA EA201000494A patent/EA017282B1/ru not_active IP Right Cessation
- 2005-03-02 RS RSP20140498 patent/RS53543B1/sr unknown
- 2005-03-02 KR KR1020067019892A patent/KR101152439B1/ko not_active Expired - Fee Related
- 2005-03-02 CN CN201510100429.2A patent/CN104817534A/zh active Pending
- 2005-03-02 DK DK12196702T patent/DK2589599T3/da active
- 2005-03-02 EP EP05716889.0A patent/EP1723135B1/en not_active Expired - Lifetime
- 2005-03-02 ME MEP-2014-113A patent/ME01955B/me unknown
- 2005-03-02 CN CN201510101394.4A patent/CN104761545A/zh active Pending
- 2005-03-02 SI SI200531772T patent/SI1723135T1/sl unknown
- 2005-03-02 KR KR1020117030419A patent/KR101152488B1/ko not_active Expired - Fee Related
- 2005-03-02 SI SI200531890T patent/SI2589599T1/sl unknown
- 2005-03-02 US US10/590,803 patent/US8003798B2/en active Active
- 2005-03-02 NZ NZ549108A patent/NZ549108A/en not_active IP Right Cessation
- 2005-03-02 PL PL12196702T patent/PL2589599T4/pl unknown
- 2005-03-02 AR ARP050100780 patent/AR049319A1/es not_active Application Discontinuation
- 2005-03-03 TW TW100110218A patent/TWI404704B/zh not_active IP Right Cessation
- 2005-03-03 TW TW094106493A patent/TWI372750B/zh not_active IP Right Cessation
2006
- 2006-07-25 IL IL177073A patent/IL177073A/en not_active IP Right Cessation
- 2006-07-26 ZA ZA200606176A patent/ZA200606176B/xx unknown
- 2006-07-28 CO CO06074146A patent/CO5700749A2/es active IP Right Grant
- 2006-09-19 NO NO20064221A patent/NO336538B1/no not_active IP Right Cessation
2011
- 2011-01-21 JP JP2011011310A patent/JP5193320B2/ja not_active Expired - Lifetime
- 2011-05-19 US US13/111,544 patent/US8324391B2/en not_active Expired - Lifetime
- 2011-05-19 US US13/111,524 patent/US8318944B2/en not_active Expired - Fee Related
2012
- 2012-08-06 IL IL221323A patent/IL221323A0/en not_active IP Right Cessation
- 2012-10-26 US US13/661,897 patent/US8455653B2/en not_active Expired - Fee Related
2013
- 2013-04-30 US US13/873,670 patent/US8883818B2/en not_active Expired - Fee Related
- 2013-09-09 CY CY20131100770T patent/CY1114319T1/el unknown
2014
- 2014-09-08 CY CY20141100722T patent/CY1115536T1/el unknown
- 2014-09-17 HR HRP20140892TT patent/HRP20140892T1/hr unknown
- 2014-10-07 US US14/508,077 patent/US9149479B2/en not_active Expired - Fee Related
- 2014-12-18 NO NO20141541A patent/NO338326B1/no not_active IP Right Cessation
2015
- 2015-08-25 US US14/834,709 patent/US9387205B2/en not_active Expired - Fee Related
- 2015-08-26 HK HK15108262.7A patent/HK1207635A1/xx unknown
- 2015-09-16 HK HK15109032.4A patent/HK1208447A1/xx unknown
- 2015-09-30 HK HK15109596.2A patent/HK1208865A1/xx unknown
2016
- 2016-01-18 HK HK16100490.7A patent/HK1214812A1/zh unknown
- 2016-06-10 US US15/179,268 patent/US9962377B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US20080167301A1 (en)	2008-07-10
JP4801039B2 (ja)	2011-10-26
WO2005085225A1 (en)	2005-09-15
IL221323A0 (en)	2012-09-24
CA2557752C (en)	2012-10-02
NZ549108A (en)	2010-06-25
US8318944B2 (en)	2012-11-27
US20140073636A1 (en)	2014-03-13
SG182194A1 (en)	2012-07-30
MXPA06009695A (es)	2007-03-26
NO20141541L (no)	2006-09-19
US9149479B2 (en)	2015-10-06
US20160279120A1 (en)	2016-09-29
JP2011074094A (ja)	2011-04-14
IL177073A (en)	2013-04-30
CY1114319T1 (el)	2016-08-31
CO5700749A2 (es)	2006-11-30
SI2589599T1 (sl)	2014-10-30
ES2505473T3 (es)	2014-10-10
RS52916B (sr)	2014-02-28
ES2427256T3 (es)	2013-10-30
EA017282B1 (ru)	2012-11-30
TW200540158A (en)	2005-12-16
CN104803974A (zh)	2015-07-29
CA2557752A1 (en)	2005-09-15
EP2589599B1 (en)	2014-06-25
EA014155B1 (ru)	2010-10-29
CN104803973A (zh)	2015-07-29
DK1723135T5 (da)	2013-09-16
US8883818B2 (en)	2014-11-11
IL177073A0 (en)	2006-12-10
ME01955B (me)	2015-05-20
HK1207635A1 (en)	2016-02-05
EP1723135B1 (en)	2013-06-19
AU2005219576A1 (en)	2005-09-15
PL2589599T3 (pl)	2015-04-30
US20150352096A1 (en)	2015-12-10
MX341474B (es)	2016-08-19
US20110257169A1 (en)	2011-10-20
PT1723135E (pt)	2013-08-29
HK1208447A1 (en)	2016-03-04
CN1922170A (zh)	2007-02-28
US8455653B2 (en)	2013-06-04
US8324391B2 (en)	2012-12-04
BRPI0508321A (pt)	2007-07-24
JP5193320B2 (ja)	2013-05-08
NO338326B1 (no)	2016-08-08
EP1723135A1 (en)	2006-11-22
TWI404704B (zh)	2013-08-11
US20110257221A1 (en)	2011-10-20
US20130045974A1 (en)	2013-02-21
TW201124381A (en)	2011-07-16
NO20064221L (no)	2006-09-19
HK1214812A1 (zh)	2016-08-05
AR049319A1 (es)	2006-07-19
US20150119389A1 (en)	2015-04-30
TWI372750B (en)	2012-09-21
EP2589599A1 (en)	2013-05-08
RS53543B1 (sr)	2015-02-27
NO336538B1 (no)	2015-09-21
CN102295634A (zh)	2011-12-28
KR101152488B1 (ko)	2012-07-02
KR20060135837A (ko)	2006-12-29
US9962377B2 (en)	2018-05-08
EA201000494A1 (ru)	2010-08-30
AU2005219576B2 (en)	2011-06-30
KR20120006080A (ko)	2012-01-17
JP2007526283A (ja)	2007-09-13
EA200601568A1 (ru)	2007-02-27
US9387205B2 (en)	2016-07-12
PL1723135T3 (pl)	2013-11-29
CN104761545A (zh)	2015-07-08
DK1723135T3 (da)	2013-09-02
HK1208865A1 (en)	2016-03-18
CY1115536T1 (el)	2017-01-04
CN104817534A (zh)	2015-08-05
HRP20130828T1 (en)	2013-09-30
PL2589599T4 (pl)	2015-06-30
PT2589599E (pt)	2014-09-02
SI1723135T1 (sl)	2013-10-30
HRP20140892T1 (hr)	2014-11-07
BRPI0508321B1 (pt)	2018-02-06
ZA200606176B (en)	2008-03-26
KR101152439B1 (ko)	2012-07-06
US8003798B2 (en)	2011-08-23

Publication	Publication Date	Title
DK1723128T3 (da)	2013-02-18	Heteroarylurinstoffer og deres anvendelse som glucokinaseaktivatorer
DK1931645T3 (da)	2014-09-29	N-(3-aminoquinoxalin-2-yl)-sulfonamidderivater og deres anvendelse som inhibitorer af phosphatidylinositol-3-kinase
DK2439205T3 (da)	2015-06-22	Carboxamidforbindelser og deres anvendelse som calpaininhibitorer
DK1954140T3 (da)	2013-06-17	Glycerollevulinatketaler og deres anvendelse
DK1841757T3 (da)	2010-09-13	Heteroaromatiske quinolin-forbindelser og deres anvendelse som PDE10-hæmmere
DK1891973T3 (da)	2010-10-18	Kombinationer omfattende antimuskarine midler og PDE4-hæmmere
DK2589599T3 (da)	2014-10-06	Hidtil ukendte hydroxy-6-heteroarylphenanthridiner og deres anvendelse som PDE4-inhibitorer
DK1753748T3 (da)	2009-10-05	Prolinderivater og deres anvendelse som dipeptidyl-peptidase-IV-inhibitorer
DK1904475T3 (da)	2011-11-21	N-thioanthranilamid-forbindelser og deres anvendelse som pesticider
DK1761529T3 (da)	2008-03-25	Pyrrolopyridinderivater og deres anvendelse som CRTh2-antagonister
ATE423121T1 (de)	2009-03-15	Diphenylimidazopyrimidin- und -imidazolamine als b-sekretase-inhibitoren
DK2099447T3 (da)	2013-02-18	Imidazotriaziner og imidazopyrimidiner som kinaseinhibitorer
DK1789401T3 (da)	2010-05-25	Isoxazolinderivater og deres anvendelse som herbicider
DK1713806T3 (da)	2013-08-05	Forbindelser og sammensætninger som proteinkinaseinhibitorer
DK1888595T3 (da)	2012-05-29	Spiro-oxindolforbindelser og deres anvendelser som terapeutiske midler
DK1480955T3 (da)	2007-10-29	O-cyclopropyl-carboxanilider og deres anvendelse som fungicider
NO20091423L (no)	2009-06-10	Pyrimidinderivater og deres anvendelse som kinaseinhibitorer
NO20044617L (no)	2004-12-28	Substituerte benzazoler og anvendelse derav som RAF kinaseinbibitorer
PT1586571E (pt)	2008-09-08	Inibidores da dipeptidil-peptidase
DK1789041T3 (da)	2008-09-08	Aryl-pyridinderivater som 11-beta-HSD1-inhibitorer
DK1586319T3 (da)	2010-02-08	Thiadiazolidinoner som GSK-3-inhibitorer
DK1797042T3 (da)	2009-03-02	Indozolonderivater som 11B-HSD1-inhibitorer
DK2305250T3 (da)	2014-04-22	Benzimidazolderivater og anvendelse heraf som proteinkinaseinhibitorer
DK1928840T3 (da)	2011-09-12	1H-pyrazol-4-carboxamider, deres fremstilling og deres anvendelse som 11-beta-hydroxysteroid-dehydrogenaseinhibitorer
DK1636228T3 (da)	2009-02-23	Nye pyridopyraziner og deres anvendelse som kinasemodulatorer